![Cancers | Free Full-Text | Activation of CD8+ T Cell Responses after Melanoma Antigen Targeting to CD169+ Antigen Presenting Cells in Mice and Humans Cancers | Free Full-Text | Activation of CD8+ T Cell Responses after Melanoma Antigen Targeting to CD169+ Antigen Presenting Cells in Mice and Humans](https://pub.mdpi-res.com/cancers/cancers-11-00183/article_deploy/html/images/cancers-11-00183-ag.png?1571050721)
Cancers | Free Full-Text | Activation of CD8+ T Cell Responses after Melanoma Antigen Targeting to CD169+ Antigen Presenting Cells in Mice and Humans
![Successful Generation of CD19 Chimeric Antigen Receptor T Cells from Patients with Advanced Systemic Lupus Erythematosus - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy Successful Generation of CD19 Chimeric Antigen Receptor T Cells from Patients with Advanced Systemic Lupus Erythematosus - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy](https://www.astctjournal.org/cms/attachment/fdb91608-6606-497d-9b36-e21ff1f00f8a/gr4.jpg)
Successful Generation of CD19 Chimeric Antigen Receptor T Cells from Patients with Advanced Systemic Lupus Erythematosus - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy
![Successful Generation of CD19 Chimeric Antigen Receptor T Cells from Patients with Advanced Systemic Lupus Erythematosus - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy Successful Generation of CD19 Chimeric Antigen Receptor T Cells from Patients with Advanced Systemic Lupus Erythematosus - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy](https://www.astctjournal.org/cms/attachment/f6815ef3-2d01-4ed8-8400-95fd5ae9af45/gr5_lrg.jpg)
Successful Generation of CD19 Chimeric Antigen Receptor T Cells from Patients with Advanced Systemic Lupus Erythematosus - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy
![Type I interferons regulate eomesodermin expression and the development of unconventional memory CD8+ T cells | Nature Communications Type I interferons regulate eomesodermin expression and the development of unconventional memory CD8+ T cells | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fncomms8089/MediaObjects/41467_2015_Article_BFncomms8089_Fig1_HTML.jpg)
Type I interferons regulate eomesodermin expression and the development of unconventional memory CD8+ T cells | Nature Communications
![Frontiers | Cytotoxic CD8+ T Cells Expressing CXCR5 Are Detectable in HIV-1 Elite Controllers After Prolonged In Vitro Peptide Stimulation Frontiers | Cytotoxic CD8+ T Cells Expressing CXCR5 Are Detectable in HIV-1 Elite Controllers After Prolonged In Vitro Peptide Stimulation](https://www.frontiersin.org/files/Articles/622343/fimmu-11-622343-HTML-r1/image_m/fimmu-11-622343-g004.jpg)
Frontiers | Cytotoxic CD8+ T Cells Expressing CXCR5 Are Detectable in HIV-1 Elite Controllers After Prolonged In Vitro Peptide Stimulation
![Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8+ T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy - ScienceDirect Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8+ T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1074761320304003-gr6.jpg)
Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8+ T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy - ScienceDirect
![Compromised Metabolic Reprogramming Is an Early Indicator of CD8+ T Cell Dysfunction during Chronic Mycobacterium tuberculosis Infection - ScienceDirect Compromised Metabolic Reprogramming Is an Early Indicator of CD8+ T Cell Dysfunction during Chronic Mycobacterium tuberculosis Infection - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124719315165-fx1.jpg)
Compromised Metabolic Reprogramming Is an Early Indicator of CD8+ T Cell Dysfunction during Chronic Mycobacterium tuberculosis Infection - ScienceDirect
![CD8+ CD226high T cells in liver metastases dictate the prognosis of colorectal cancer patients treated with chemotherapy and radical surgery | Cellular & Molecular Immunology CD8+ CD226high T cells in liver metastases dictate the prognosis of colorectal cancer patients treated with chemotherapy and radical surgery | Cellular & Molecular Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41423-023-00978-2/MediaObjects/41423_2023_978_Figa_HTML.png)
CD8+ CD226high T cells in liver metastases dictate the prognosis of colorectal cancer patients treated with chemotherapy and radical surgery | Cellular & Molecular Immunology
![The prognostic role of circulating CD8+ T cell proliferation in patients with untreated extensive stage small cell lung cancer | Journal of Translational Medicine | Full Text The prognostic role of circulating CD8+ T cell proliferation in patients with untreated extensive stage small cell lung cancer | Journal of Translational Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12967-019-02160-7/MediaObjects/12967_2019_2160_Fig1_HTML.png)
The prognostic role of circulating CD8+ T cell proliferation in patients with untreated extensive stage small cell lung cancer | Journal of Translational Medicine | Full Text
![Multiomics and spatial mapping characterizes human CD8+ T cell states in cancer | Science Translational Medicine Multiomics and spatial mapping characterizes human CD8+ T cell states in cancer | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.add1016/asset/52692a60-c4a6-48d8-a2ee-be3e7c1ef03c/assets/images/large/scitranslmed.add1016-f5.jpg)
Multiomics and spatial mapping characterizes human CD8+ T cell states in cancer | Science Translational Medicine
![Helminth-induced IL-4 expands bystander memory CD8+ T cells for early control of viral infection | Nature Communications Helminth-induced IL-4 expands bystander memory CD8+ T cells for early control of viral infection | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-018-06978-5/MediaObjects/41467_2018_6978_Fig1_HTML.png)
Helminth-induced IL-4 expands bystander memory CD8+ T cells for early control of viral infection | Nature Communications
![Keystone, Stéréo, Belgium, Namur, from the fortress hill by Photographie originale / Original photograph: (1900) Photograph | photovintagefrance Keystone, Stéréo, Belgium, Namur, from the fortress hill by Photographie originale / Original photograph: (1900) Photograph | photovintagefrance](https://pictures.abebooks.com/inventory/31523446980.jpg)
Keystone, Stéréo, Belgium, Namur, from the fortress hill by Photographie originale / Original photograph: (1900) Photograph | photovintagefrance
![Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression | Journal for ImmunoTherapy of Cancer Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression | Journal for ImmunoTherapy of Cancer](https://jitc.bmj.com/content/jitc/11/5/e005719/F1.large.jpg)
Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression | Journal for ImmunoTherapy of Cancer
![Radiomics to predict outcomes and abscopal response of patients with cancer treated with immunotherapy combined with radiotherapy using a validated signature of CD8 cells | Journal for ImmunoTherapy of Cancer Radiomics to predict outcomes and abscopal response of patients with cancer treated with immunotherapy combined with radiotherapy using a validated signature of CD8 cells | Journal for ImmunoTherapy of Cancer](https://jitc.bmj.com/content/jitc/8/2/e001429/F3.large.jpg)